共 50 条
- [42] TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (04): : 430 - 436
- [45] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients Journal of Neuro-Oncology, 2022, 158 : 111 - 116
- [46] The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival CANCER MEDICINE, 2018, 7 (08): : 3704 - 3712